Chimerix Announces Successful Launch of ONC201 Phase 3 ACTION Study at Society for Neuro-Oncology Conference and Provides Operational Update
– Natural Disease History study indicates median overall survival in recurrent H3 K27M-mutant diffuse glioma of…
Novee Launches Agentic Fix to Turn Validated Exploits into Implemented Fixes
The AI Search Shift: A Survival Guide for CMOs, PR Professionals, and Website Managers
An Architectural Approach to Solving Prompt Security Challenges
Optical Networking At Micro Scale